1.
Am J Psychiatry
; 175(3): 209-214, 2018 03 01.
Article
in English
| MEDLINE
| ID: mdl-29490501
2.
Psychiatr Clin North Am
; 39(2): 275-311, 2016 06.
Article
in English
| MEDLINE
| ID: mdl-27216904
ABSTRACT
Antipsychotics are some of the most frequently prescribed medications not only for psychotic disorders and symptoms but also for a wide range of on-label and off-label indications. Because second-generation antipsychotics have largely replaced first-generation antipsychotics as first-line options due to their substantially decreased risk of extrapyramidal side effects, attention has shifted to other clinically concerning adverse events associated with antipsychotic therapy. The focus of this article is to update the nonextrapyramidal side effects associated with second-generation antipsychotics. Issues surrounding diagnosis and monitoring as well as clinical management are addressed.
Subject(s)
Antipsychotic Agents/adverse effects , Psychotic Disorders/complications , Dementia/complications , Dementia/drug therapy , Disease Management , Humans , Hyperlipidemias/chemically induced , Hyperlipidemias/complications , Hyperprolactinemia/chemically induced , Hyperprolactinemia/complications , Hyperprolactinemia/epidemiology , Long QT Syndrome/chemically induced , Long QT Syndrome/complications , Osteoporosis/chemically induced , Osteoporosis/complications , Psychotic Disorders/drug therapy , Psychotic Disorders/mortality , Risk Factors , Sexual Dysfunction, Physiological/chemically induced , Sexual Dysfunction, Physiological/complications , Sexual Dysfunction, Physiological/epidemiology , Sexual Dysfunctions, Psychological/chemically induced , Sexual Dysfunctions, Psychological/complications , Sexual Dysfunctions, Psychological/epidemiology , Weight Gain
3.
J Neuropsychiatry Clin Neurosci
; 28(1): e6-7, 2016.
Article
in English
| MEDLINE
| ID: mdl-26844969